C/EBPβ promotes the expression of atrophy‐inducing factors by tumours and is a central regulator of cancer cachexia
Abstract Background CCAAT/enhancer‐binding protein β (C/EBPβ) is a transcription factor whose high expression in human cancers is associated with tumour aggressiveness and poor outcomes. Most advanced cancer patients will develop cachexia, characterized by loss of skeletal muscle mass. In response t...
Saved in:
Main Authors: | Hamood AlSudais (Author), Rashida Rajgara (Author), Aisha Saleh (Author), Nadine Wiper‐Bergeron (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumour‐derived transforming growth factor‐β signalling contributes to fibrosis in patients with cancer cachexia
by: Joanna D.C.C. Lima, et al.
Published: (2019) -
C/EBP-β and SIRT1 regulate IL-18 expression in the proliferative phase endometria of polycystic ovary syndrome patients
by: Xiaoyu Long, et al.
Published: (2021) -
The detection of C/EBPβ expression in the lesions of patients with psoriasis vulgaris by Western blot
by: Li-dan LIU, et al.
Published: (2019) -
TGF-β-induced α-SMA expression is mediated by C/EBPβ acetylation in human alveolar epithelial cells
by: Hui Ding, et al.
Published: (2021) -
Correction to: TGF‑β‑induced α‑SMA expression is mediated by C/EBPβ acetylation in human alveolar epithelial cells
by: Hui Ding, et al.
Published: (2021)